Genpharmasec Ltd Stock Analysis

BSE: 531592 | NSE: | Dyes & Pigments | Small Cap

BSE Share Price Jan 25, 14:35
7.86 -0.07 (-0.88%)

DeciZen - Make an Informed Decision on Genpharmasec

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation


3. Price Trend


1. Is Genpharmasec Ltd a good quality company?

Data is not available for this company.

2. Is Genpharmasec Ltd undervalued or overvalued?

The key valuation ratios of Genpharmasec Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Genpharmasec Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Genpharmasec Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Genpharmasec:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
ROCE % -347.9%12.8%76.6%61.9%33.9%15.9%36%2%5%6.3%-
Value Creation Index NA-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 0.30.40000.50.10.416.521.322
YoY Gr. Rt. %-44%-100%NA-100%NA-83.3%375%4,242.1%29.2%-
Adj EPS -000000.
YoY Gr. Rt. %-NANANANANA200%-93.3%400%0%-
BVPS (₹) -0.2-0.2-0.2-0.2-0.1-2.8-
Adj Net Profit -0.1000000.10.211.32
Cash Flow from Ops. -0.10000.1-0.10.1-6.41.4-2.1-
Debt/CF from Ops. -11.5-114.861.3399.7-21.36.8000-


CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales 63.9%NA543.4%29.2%
Adj EPS NANA-30.7%0%
BVPS 000-7.4
Share Price 31.2% 23.6% -11.9% -18%

Key Financial Parameters

Performance Ratio Colour Code Guide
Return on Equity % 12.9-0.5-1.9-2.1-1.8-1.7-
Op. Profit Mgn % -53.71.40-2245.10-12.4-31.4-
Net Profit Mgn % -53.71.40129.503.258.557.
Debt to Equity -1-1-1-1.1-1.1-1.2-1.10000
Working Cap Days 70944402,17601991,1524,331279281417
Cash Conv. Cycle 69143302,111011-1,8041742123308

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 9.50%

Sales growth is growing at healthy rate in last 3 years 543.42%

Sales growth is good in last 4 quarters at 10.94%

Net Profit has been subdued in last 3 years -30.66%

Latest Financials - Genpharmasec Ltd.

Standalone Consolidated
TTM EPS (₹) 0.1 -
TTM Sales (₹ Cr.) 22.3 -
BVPS (₹.) 0.7 -
Reserves (₹ Cr.) -7 -
P/BV 10.87 -
PE 106.53 -
From the Market
52 Week Low / High (₹) 5.20 / 12.40
All Time Low / High (₹) 0.21 / 18.00
Market Cap (₹ Cr.) 220
Equity (₹ Cr.) 27.7
Face Value (₹) 1
Industry PE 25.8

Management X-Ray of Genpharmasec :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes


About Genpharmasec Ltd

Adi Rasayan Limited was incorporated as Public Limited Company on November 16, 1992 and obtained Commencement of Business Certificate on November 20, 1992 with the object, of manufacturing and trading in organic and inorganic chemicals dyes and pigments. The company was promoted by Sanjay J. Adani, Dinesh H. Desai, Dahyabhai Patel, Vikram R. Shah and Mitesh J. Adani and family members.

Subsequently, during October 1994 Shashikant M. Gandhi joined as co-promoter. In early 1993, it was decided by the, Board to set up the project. In April 1993 land admeasuring 19095.36 square metres was acquired at GIDC Industrial Estate, Panoli, Ankleshwar, Bharuch District, Gujarat, for the project. In July 1994, and in December 1994 the company obtained acknowledgements of Memoranda for its products. The company is presently implementing the project. The company is also carrying out a small amount of trading in chemicals.

Adi Rasayan`s registered office is located at Gujarat, India.

Products & Services

  • Pigments, natural
  • Pigments, synthetic


Read More Read Less